PF-Atlas › Clinical Trials › NCT06150560
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling
Losartan · Phase 3
Registry ID
NCT06150560
Phase
Phase 3
Status
Recruiting
Drug / intervention
Losartan
Sponsor
Mayo Clinic
Start
2024-04-01
About this trial
Losartan is evaluated in NCT06150560, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Mayo Clinic. Current status: Recruiting.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT06150560 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.